<?xml version="1.0" encoding="UTF-8"?>
<p>HeV infection in humans can be prevented by avoiding contact with infected horses or avoiding exposure to infected substances by implementing infection control (IC) measures such as using personal protective equipment (PPE) [
 <xref ref-type="bibr" rid="CR13">13</xref>]. Administration of monoclonal antibodies during the incubation period has been shown to prevent experimentally induced HeV disease in ferrets and non-human primate models and this has also been used in humans exposed to HeV as an experimental prophylaxis [
 <xref ref-type="bibr" rid="CR14">14</xref>]. A vaccine for horses became available in late 2012 and was promoted for the protection of horse populations from HeV and humans from secondary spillover [
 <xref ref-type="bibr" rid="CR15">15</xref>,
 <xref ref-type="bibr" rid="CR16">16</xref>].
</p>
